Indolent B cell lymphoma

Common Name(s)

Indolent B cell lymphoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Indolent B cell lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Indolent B cell lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Indolent B cell lymphoma" returned 31 free, full-text research articles on human participants. First 3 results:

Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma.
 

Author(s): H Saito, D Maruyama, A M Maeshima, S Makita, H Kitahara, K Miyamoto, S Fukuhara, W Munakata, T Suzuki, Y Kobayashi, H Taniguchi, K Tobinai

Journal:

 

Last Updated: 27 Oct 2015

Go To URL
Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study.
 

Author(s): Laurie H Sehn, Andre Goy, Fritz C Offner, Giovanni Martinelli, M Dolores Caballero, Ole Gadeberg, Tara Baetz, Andrew D Zelenetz, Gianluca Gaidano, Luis E Fayad, Rena Buckstein, Jonathan W Friedberg, Michael Crump, Branimir Jaksic, Pier Luigi Zinzani, Swaminathan Padmanabhan Iyer, Deniz Sahin, Akiko Chai, Günter Fingerle-Rowson, Oliver W Press

Journal: J. Clin. Oncol.. 2015 Oct;33(30):3467-74.

 

Obinutuzumab (GA101), a novel glycoengineered type II anti-CD20 monoclonal antibody, demonstrated responses in single-arm studies of patients with relapsed/refractory non-Hodgkin lymphoma. This is the first prospective, randomized study comparing safety and efficacy of obinutuzumab ...

Last Updated: 19 Oct 2015

Go To URL
Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group.
 

Author(s): Tomoyuki Sakai, Yasufumi Masaki, Nozomi Otsuki, Ippei Sakamaki, Shinji Kishi, Takayoshi Miyazono, Yoshimasa Urasaki, Jun Murakami, Tomomi Satoh, Takuji Nakamura, Haruka Iwao, Akio Nakajima, Takafumi Kawanami, Miyuki Miki, Yoshimasa Fujita, Masao Tanaka, Toshihiro Fukushima, Toshiro Okazaki, Takanori Ueda

Journal: Med. Oncol.. 2015 Sep;32(9):232.

 

Standardized treatments for indolent B cell lymphoma primarily consisting of follicular lymphoma (FL) and for mantle cell lymphoma (MCL) have yet to be established. Here the Hokuriku Hematology Oncology Study Group conducted a multicenter prospective study to investigate the efficacy ...

Last Updated: 15 Aug 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Indolent B cell lymphoma" returned 1 free, full-text review articles on human participants. First 3 results:

Pathology of indolent B-cell neoplasms other than follicular lymphoma.
 

Author(s): Seiji Sakata, Naoko Tsuyama, Kengo Takeuchi

Journal: J Clin Exp Hematop. 2014 ;54(1):11-22.

 

Indolent B-cell lymphomas include follicular lymphoma (FL), chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and marginal zone lymphomas (MZLs). They are a diverse group of disorders with different clinical, morphological, immunophenotypic and genetic features. However, ...

Last Updated: 19 Jun 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Indolent Non Follicular Lymphomas Prognostic Project
 

Status: Recruiting

Condition Summary: Indolent B-Cell Lymphomas

 

Last Updated: 22 Mar 2017

Go to URL
Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers
 

Status: Recruiting

Condition Summary: Chronic Lymphocytic Leukemia; Indolent B-cell Lymphomas; Chronic Hepatitis B; Lymphoma, Small Lymphocytic; Mantle-Cell Lymphoma; Waldenstrom's Macroglobulinaemia; Follicular Lymphoma

 

Last Updated: 8 Dec 2016

Go to URL